Medical policy
Proposed local coverage determination: Contractor advisory committee (CAC) meetings
Contractor advisory committee (CAC) meeting information and upcoming CAC meetings
Proposed local coverage determination: Contractor advisory committee (CAC) meetings
Contractor advisory committee (CAC) meeting information and upcoming CAC meetings
Reporting the national drug code
Read this article for helpful information to report the national drug code on claims.
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated April 8.
Prior authorization for ambulance transports is for repetitive transports
A repetitive service is defined as medically necessary ambulance transportation that is furnished three or more times during a 10-day period OR at least once per week for at least three weeks.…
Prior authorization for ambulance transports is for repetitive transports
A repetitive service is defined as medically necessary ambulance transportation that is furnished three or more times during a 10-day period OR at least once per week for at least three weeks.…
SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements
View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.
SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements
View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its documentation requirements.